跳至主要内容
临床试验/IRCT138706171100N2
IRCT138706171100N2已完成2 期

A randomized clinical trial for the evaluation of the efficacy of 30 mCi versus 100 mCi, 131I for ablation of residual thyroid tissue

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 341 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
341

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with differentiated thyroid carcinoma (DTC): without any history of ablation therapy; with no palpable mass in the neck; with no evidence of capsular; vascular or lymph node invasion. Exclusion criteria: Any area of I-131 uptake in post-treatment whole body scan; Failing to follow the patients.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验